Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

PINKvsFTXHETF Comparison

ETF 1
PINK

Simplify Health Care ETF

This fund is part of
Healthcare Technology
-1.39%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-0.94%

Simplify Health Care ETF (PINK) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. PINK's top 3 sector exposures are Healthcare, Non-Energy Materials and Consumer Cyclicals. In contrast, FTXH's top sector exposures are Healthcare. PINK is less expensive with a Total Expense Ratio (TER) of 0.51%, versus 0.6% for FTXH. PINK is up 8.13% year-to-date (YTD) with +$8M in YTD flows. FTXH performs better with 25.9% YTD performance, and +$965M in YTD flows. Run a side-by-side ETF comparison of PINK and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PINK vs FTXH performance and flow charts

Performance

-2.00.02.04.06.08.0%Jul 28Aug 4Aug 11Aug 18Aug 25

Cumulative Flows

0 M20 M40 M60 M80 M100 M120 MJul 28Aug 4Aug 11Aug 18Aug 25

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/28/2026
1M3MYTD1Y3Y5Y
Perf.
PINK
FTXH
-0.26%+4.17%
+3.85%+17.69%
+8.13%+25.90%
+30.39%+51.61%
+52.81%+60.12%
n/a+65.87%
Flows
PINK
FTXH
-$1M+$119M
+$96M+$953M
+$8M+$965M
+$190M+$969M
+$230M+$960M
-+$960M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PINK
FTXH
+16.83%+20.73%
+18.03%+17.63%
+17.12%+16.96%
n/a+16.32%
Max drawdown
PINK
FTXH
-4.76%-4.43%
-16.68%-7.50%
-18.81%-19.32%
n/a-19.32%
Max drawdown duration
PINK
FTXH
33d20d
154d99d
390d393d
n/a393d
Trading data

Create an account to view trading data

Join for free
PINK
FTXH
Last sale
8/28/2026 at 1:30 PM
$39.37
$41.33
Previous close
08/28/2026
$39.99
$42.00
Consolidated volume
08/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

PINK
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PINK
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/28/2026 at 1:30 PM
Live
Closed
PINK
FTXH
Last price
$39.37
$41.33
1D performance
-1.55%
-1.60%
AuM$375.37 M$1.05 B
E/R0.51%0.6%
Characteristics
PINK
FTXH
Management strategyActivePassive
ProviderSimplifyFirst Trust
Benchmark-NASDAQ US Smart Pharmaceuticals Index
N° of holdings4949
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 7, 2021September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

PINK
USA
86.58%
Denmark
7.14%
Other
6.29%
FTXH
USA
95.79%
Other
4.21%

Sectors

PINK
Healthcare
87.2%
Other
12.8%
FTXH
Healthcare
99.86%
Other
0.14%

Diversification

PINK

Total weight of top 15 holdings out of 15

72.03%
FTXH

Total weight of top 15 holdings out of 15

66.98%

Top 15 holdings

Data as of July 31, 2026
PINK
Novo Nordisk A/S
7.14%
Thermo Fisher Scientific, Inc.
6.87%
United Therapeutics Corp.
6.82%
Purecycle Technologies, Inc.
5.19%
Johnson & Johnson
5.02%
Eli Lilly & Co.
5.01%
Jazz Pharmaceuticals Plc
4.98%
UnitedHealth Group, Inc.
4.88%
AbbVie, Inc.
4.71%
Warby Parker, Inc.
4.15%
10X Genomics, Inc.
3.83%
Danaher Corp.
3.50%
Biohaven Ltd.
3.33%
Benitec Biopharma, Inc.
3.31%
Quest Diagnostics, Inc.
3.28%
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
Frequently asked questions about PINK and FTXH

How have the PINK and FTXH ETFs performed in 2026?

As of August 28, 2026, PINK is up 8.13% year-to-date (YTD), while FTXH has returned 25.9%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: PINK or FTXH?

Year-to-date, the PINK ETF saw +$8M in flows, compared to +$965M for FTXH.

Which ETF is more volatile: PINK or FTXH?

Over the past year, PINK had a volatility of 18.03%, while FTXH experienced 17.63%.

Which ETF is bigger: PINK or FTXH?

As of August 28, 2026, PINK holds $375.37 M in assets under management (AUM), while FTXH manages $1.05 B.

What sectors do the PINK and FTXH ETFs invest in?

PINK leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the PINK ETF and FTXH ETF?

PINK top holdings include Novo Nordisk A/S, Thermo Fisher Scientific, Inc. and United Therapeutics Corp.. FTXH holds in its top three: Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc..

Which ETF is more diversified: PINK or FTXH?

PINK holds 49 securities with 72.03% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 66.98%.

Advertisement
Latest news about PINK & FTXH
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder